Chinook Therapeutics Inc Cvr (ADRO)
Stock-Based Compensation
$9.02M
TTM · Period ending: · USD
ADRO Stock-Based Compensation
Latest reported$9.02Mperiod ending
Latest reported$9.02Mperiod ending
ADRO TTM Stock-Based Comp ($570.00K → $9.02M)
TTM stock-based compensation
High-resolution chart · PNG
ADRO stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 9,020,000 | |
| 10,463,000 | |
| 10,771,000 | |
| 12,439,000 | |
| 14,116,000 | |
| 15,262,000 | |
| 16,253,000 | |
| 17,474,000 | |
| 17,838,000 | |
| 17,642,000 | |
| 17,312,000 | |
| 16,376,000 | |
| 16,164,000 | |
| 15,923,000 | |
| 15,251,000 | |
| 15,006,000 | |
| 14,050,000 | |
| 12,153,000 | |
| 11,593,000 | |
| 8,430,000 | |
| 5,434,000 | |
| 3,711,000 | |
| 1,041,000 | |
| 570,000 |